Organovo Holdings Inc. (ONVO) Financial Statements (2024 and earlier)
Company Profile
Business Address |
11555 SORRENTO VALLEY ROAD SAN DIEGO, CA 92121 |
State of Incorp. | DE |
Fiscal Year End | March 31 |
Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2024 MRQ | 3/31/2024 | 12/31/2023 MRQ | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 2,901 | 5,295 | 16,001 | 28,675 | 37,364 | 27,356 | |||
Cash and cash equivalents | 2,901 | 5,295 | 15,301 | 28,675 | 37,364 | 27,356 | |||
Short-term investments | 700 | ||||||||
Receivables | 33 | 33 | 152 | 111 | |||||
Inventory, net of allowances, customer advances and progress billings | 297 | ||||||||
Inventory | 297 | ||||||||
Prepaid expense | 256 | ||||||||
Other current assets | 4 | ||||||||
Other undisclosed current assets | 445 | 913 | 895 | 858 | 1,034 | 851 | |||
Total current assets: | 3,936 | 6,241 | 17,048 | 29,533 | 38,398 | 28,318 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 1,299 | 1,403 | 1,705 | 2,153 | |||||
Property, plant and equipment | 669 | 739 | 902 | 662 | 381 | ||||
Restricted cash and investments | 100 | 143 | 100 | 100 | 100 | ||||
Other noncurrent assets | 1,027 | 123 | |||||||
Other undisclosed noncurrent assets | 345 | 355 | 558 | 848 | 11 | ||||
Total noncurrent assets: | 2,413 | 2,640 | 3,265 | 3,763 | 1,519 | 123 | |||
TOTAL ASSETS: | 6,349 | 8,881 | 20,313 | 33,296 | 39,917 | 28,441 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 1,354 | 1,198 | 3,179 | 904 | 721 | 1,810 | |||
Accounts payable | 627 | 471 | 331 | 415 | 281 | 720 | |||
Accrued liabilities | 727 | 727 | 2,848 | 489 | 440 | 1,090 | |||
Other liabilities | 98 | 191 | |||||||
Other undisclosed current liabilities | 408 | 311 | 492 | 479 | |||||
Total current liabilities: | 1,860 | 1,700 | 3,671 | 1,383 | 721 | 1,810 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 1,704 | ||||||||
Liabilities, other than long-term debt | 2,588 | 999 | 1,313 | ||||||
Liability for uncertainty in income taxes | 1,700 | ||||||||
Operating lease, liability | 888 | 999 | 1,313 | 1,704 | |||||
Other undisclosed noncurrent liabilities | (1,700) | (1,704) | |||||||
Total noncurrent liabilities: | 888 | 999 | 1,313 | 1,704 | |||||
Total liabilities: | 2,748 | 2,699 | 4,984 | 3,087 | 721 | 1,810 | |||
Equity | |||||||||
Equity, attributable to parent | 3,601 | 6,182 | 15,329 | 30,209 | 39,196 | 26,631 | |||
Common stock | 10 | 10 | 9 | 9 | 9 | 131 | |||
Treasury stock, value | (1) | (1) | (1) | (1) | (1) | ||||
Additional paid in capital | 343,261 | 342,796 | 340,317 | 337,940 | 335,479 | 305,965 | |||
Accumulated other comprehensive income | 1 | 2 | |||||||
Accumulated deficit | (339,669) | (336,624) | (324,998) | (307,739) | (296,291) | (279,465) | |||
Total equity: | 3,601 | 6,182 | 15,329 | 30,209 | 39,196 | 26,631 | |||
TOTAL LIABILITIES AND EQUITY: | 6,349 | 8,881 | 20,313 | 33,296 | 39,917 | 28,441 |
Income Statement (P&L) ($ in thousands)
6/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 109 | 450 | 370 | 1,500 | 2,196 | |||
Cost of revenue | (300) | |||||||
Cost of goods and services sold | (328) | |||||||
Gross profit: | 109 | 80 | 370 | 1,500 | 1,896 | |||
Operating expenses | (15,595) | (20,605) | (18,101) | (12,979) | (16,826) | (23,343) | ||
Other undisclosed operating income (loss) | 400 | 370 | (28) | |||||
Operating loss: | (15,086) | (20,155) | (17,731) | (11,479) | (16,826) | (21,475) | ||
Nonoperating income | 417 | 809 | 474 | 33 | 2 | 2,767 | ||
Investment income, nonoperating | 405 | 354 | 454 | 8 | 15 | 594 | ||
Other nonoperating income | 25 | 6 | 1,535 | |||||
Loss from continuing operations before income taxes: | (14,669) | (19,346) | (17,257) | (11,446) | (16,824) | (18,708) | ||
Income tax expense | (2) | (2) | (2) | (2) | (2) | (2) | ||
Loss from continuing operations: | (14,671) | (19,348) | (17,259) | (11,448) | (16,826) | (18,710) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (11,448) | (16,826) | (18,710) | |
Net loss available to common stockholders, diluted: | (14,671) | (19,348) | (17,259) | (11,448) | (16,826) | (18,710) |
Comprehensive Income ($ in thousands)
6/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (14,671) | (19,348) | (17,259) | (11,448) | (16,826) | (18,710) | ||
Comprehensive loss: | (14,671) | (19,348) | (17,259) | (11,448) | (16,826) | (18,710) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2) | 1 | 2 | |||||
Comprehensive loss, net of tax, attributable to parent: | (14,673) | (19,347) | (17,257) | (11,448) | (16,826) | (18,710) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.